Danaher Corporation $DHR Shares Sold by Blair William & Co. IL

Key Points

• Blair William & Co. IL reduced its stake in Danaher Corporation by 4.7%, now owning approximately 1,375,724 shares valued at $271.76 million.
• Danaher reported $1.80 EPS for the last quarter, exceeding expectations of $1.64, with a revenue of $5.94 billion, which is an increase of 3.4% year-over-year.
• The company recently announced a quarterly dividend of $0.32 per share, representing an annualized payment of $1.28 with a dividend yield of 0.6%.

Blair William & Co. IL cut its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 4.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,375,724 shares of the conglomerate's stock after selling 68,056 shares during the period. Danaher accounts for approximately 0.8% of Blair William & Co. IL's holdings, making the stock its 27th biggest holding. Blair William & Co. IL owned approximately 0.19% of Danaher worth $271,761,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. GHP Investment Advisors Inc. increased its position in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares in the last quarter. Sierra Ocean LLC grew its stake in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher during the first quarter worth approximately $31,000. Red Tortoise LLC lifted its holdings in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Finally, Dunhill Financial LLC lifted its holdings in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 67 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Down 1.7%

Shares of Danaher stock opened at $205.13 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The firm has a market cap of $146.88 billion, a P/E ratio of 43.64, a P/E/G ratio of 2.97 and a beta of 0.77. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41. The business has a 50-day moving average price of $200.41 and a 200 day moving average price of $197.38.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business's revenue was up 3.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's dividend payout ratio is 27.23%.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of the business's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on DHR shares. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Robert W. Baird boosted their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Evercore ISI lifted their price target on shares of Danaher from $226.00 to $245.00 and gave the stock an "outperform" rating in a research note on Tuesday. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Danaher in a research note on Wednesday. Finally, Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a research report on Tuesday, September 2nd. Seventeen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $244.60.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.